This is your one stop shop for updates on CTTI projects, developments in the clinical trials enterprise and other relevant news. To read the full-length entry, or to share a specific blog post, click on the title of the article of interest.
Apply Filter View All
The time to create true and lasting change in clinical trials is now. Together, we can harness our experiences and momentum from COVID-19 to shape a future of smarter, faster research.
CTTI’s vision, Transforming Trials 2030, is that clinical trials in 2030 will be:
...
A recording for CTTI’s public summit, The Fastest Path to Effective COVID-19 Treatments: Using Master Protocol Studies , held Jan. 13, is now available. The summit, conducted as a webinar, opened with a welcome from Janet Woodcock , Operation Warp Speed; a call-to-action from Robert M. Califf , Verily and Google Health; and included three panel discussions focused on solutions related to scaling master protocols....
CTTI will host a public summit , The Fastest Path to Effective COVID-19 Treatments: Using Master Protocol Studies , on Wednesday, January 13. The summit, conducted as a webinar and moderated by CTTI Executive Director Pamela Tenaerts , will include a welcome from Janet Woodcock , Operation Warp Speed; a call-to-action from Robert M. Califf , Verily and Google Health; remarks from Mark McClellan , Duke-Margolis Center for Health Policy; and a panel discussion moderated by ...
Although treatment of possible nosocomial pneumonia is common with patients in the intensive care unit (ICU) receiving respiratory support, more than half of those treated do not fit the standard clinical definitions of hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP). A new CTTI paper available online in CHEST® Journal, accompanied by an insightful editorial, “ Heeding the Prophetic Call ,” outlines how the use of simple clinical criteria may help to identify high-risk patients earlier and aid future research...
A recording is now available of the public webinar held on Thurs., Nov. 12 to launch CTTI’s new resources for implementing a Quality by Design (QbD) approach to clinical trials. The webinar was led by Greg Pennock, EMD Serono; David Rodin, Amici Clinical Research; Karlin Schroeder, Parkinson’s Foundation; Ansalan Stewart, FDA; and Steve Young, CluePoints.
“We have worked with leaders and all stakeholders across the clinical trials ecosystem to develop new resources that...
